Covalent inhibition of bacterial quorum sensing

Details for Australian Patent Application No. 2010267596 (hide)

Owner National Institute For Biotechnology in the Negev

Inventors Meijler, Michael M.; Amara, Neri; Rayo, Josep

Agent Shelston IP

Pub. Number AU-A-2010267596

PCT Pub. Number WO2011/001419

Priority 61/222,944 03.07.09 US

Filing date 4 July 2010

Wipo publication date 6 January 2011

International Classifications

C07D 307/32 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/001419 Priority application(s): WO2011/001419

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010267626-Ethylene/vinyl acetate/unsaturated esters terpolymer as an additive for improving the resistance to cold of liquid hydrocarbons such as middle distillates and fuels

2010267590-Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor